Manuka, Inc. (MNKA)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 12:45PM EDT. Market open.
| Previous close | 0.0300 |
| Open | 0.0300 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 0.0300 - 0.0300 |
| 52-week range | 0.0100 - 1.8900 |
| Volume | |
| Avg. volume | 808 |
| Market cap | 3.361M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Manuka Announces Review of Strategic Alternatives
Manuka Inc.Petach Tikva, Israel, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Manuka, Inc. ("Manuka" or the "Company") (OTCPINK:MNKA), a beauty company that develops and distributes premium-quality skincare products that are based on Manuka honey and bee venom, announced today that following a review of its business, resources and capabilities, it is exploring strategic alternatives focused on maximizing stockholder value. As part of this process, the Company has engaged ACP Capital Markets LLC (“ACP”) as
© 2024 Yahoo. All rights reserved.